Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13


sCLIP-an integrated platform to study RNA-protein interactomes in biomedical research: identification of CSTF2tau in alternative processing of small nuclear RNAs.

Kargapolova Y, Levin M, Lackner K, Danckwardt S.

Nucleic Acids Res. 2017 Jun 2;45(10):6074-6086. doi: 10.1093/nar/gkx152.


Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice.

Steven S, Jurk K, Kopp M, Kröller-Schön S, Mikhed Y, Schwierczek K, Roohani S, Kashani F, Oelze M, Klein T, Tokalov S, Danckwardt S, Strand S, Wenzel P, Münzel T, Daiber A.

Br J Pharmacol. 2017 Jun;174(12):1620-1632. doi: 10.1111/bph.13549. Epub 2016 Aug 21.


Processing and transcriptome expansion at the mRNA 3' end in health and disease: finding the right end.

Ogorodnikov A, Kargapolova Y, Danckwardt S.

Pflugers Arch. 2016 Jun;468(6):993-1012. doi: 10.1007/s00424-016-1828-3. Epub 2016 May 25. Review.


The Importance of Thrombin in Cerebral Injury and Disease.

Krenzlin H, Lorenz V, Danckwardt S, Kempski O, Alessandri B.

Int J Mol Sci. 2016 Jan 11;17(1). pii: E84. doi: 10.3390/ijms17010084. Review.


Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond.

Danckwardt S, Hentze MW, Kulozik AE.

J Mol Med (Berl). 2013 Nov;91(11):1257-71. doi: 10.1007/s00109-013-1074-5. Epub 2013 Aug 17. Review.


p38 MAPK controls prothrombin expression by regulated RNA 3' end processing.

Danckwardt S, Gantzert AS, Macher-Goeppinger S, Probst HC, Gentzel M, Wilm M, Gröne HJ, Schirmacher P, Hentze MW, Kulozik AE.

Mol Cell. 2011 Feb 4;41(3):298-310. doi: 10.1016/j.molcel.2010.12.032.


Downregulation of Notch signaling by gamma-secretase inhibition can abrogate chemotherapy-induced apoptosis in T-ALL cell lines.

Liu S, Breit S, Danckwardt S, Muckenthaler MU, Kulozik AE.

Ann Hematol. 2009 Jul;88(7):613-21. doi: 10.1007/s00277-008-0646-x. Epub 2008 Dec 5.


3' end mRNA processing: molecular mechanisms and implications for health and disease.

Danckwardt S, Hentze MW, Kulozik AE.

EMBO J. 2008 Feb 6;27(3):482-98. doi: 10.1038/sj.emboj.7601932. Review.


Splicing factors stimulate polyadenylation via USEs at non-canonical 3' end formation signals.

Danckwardt S, Kaufmann I, Gentzel M, Foerstner KU, Gantzert AS, Gehring NH, Neu-Yilik G, Bork P, Keller W, Wilm M, Hentze MW, Kulozik AE.

EMBO J. 2007 Jun 6;26(11):2658-69. Epub 2007 Apr 26.


The prothrombin 20209 C-->T mutation in Jewish-Moroccan Caucasians: molecular analysis of gain-of-function of 3' end processing.

Danckwardt S, Hartmann K, Katz B, Hentze MW, Levy Y, Eichele R, Deutsch V, Kulozik AE, Ben-Tal O.

J Thromb Haemost. 2006 May;4(5):1078-85.


3' end processing of the prothrombin mRNA in thrombophilia.

Danckwardt S, Hartmann K, Gehring NH, Hentze MW, Kulozik AE.

Acta Haematol. 2006;115(3-4):192-7. Review.


The prothrombin 3'end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations.

Danckwardt S, Gehring NH, Neu-Yilik G, Hundsdoerfer P, Pforsich M, Frede U, Hentze MW, Kulozik AE.

Blood. 2004 Jul 15;104(2):428-35. Epub 2004 Apr 1.


Abnormally spliced beta-globin mRNAs: a single point mutation generates transcripts sensitive and insensitive to nonsense-mediated mRNA decay.

Danckwardt S, Neu-Yilik G, Thermann R, Frede U, Hentze MW, Kulozik AE.

Blood. 2002 Mar 1;99(5):1811-6.

Supplemental Content

Loading ...
Support Center